A carregar...

A review of ramelteon in the treatment of sleep disorders

Ramelteon is a selective melatonin receptor (MT(1) and MT(2)) agonist that has been approved by the US Food and Drug Administration for the treatment of insomnia characterized by difficulty with sleep onset. It is the only approved sleep-promoting medication that does not have a direct sedating effe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: Neubauer, David N
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2008
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2515902/
https://ncbi.nlm.nih.gov/pubmed/18728808
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!